Corydalis decumbens
What's the taxonomical classification of Corydalis decumbens?
Corydalis decumbens belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within the class Equisetopsida and the subclass Magnoliidae, it is further organized into the order Ranunculales. This plant is a member of the family Papaveraceae, falling under the genus Corydalis, and is specifically identified by the species name decumbens.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Corydalis |
| Species | decumbens |
What are the morphological characteristics of this plant?
Corydalis decumbens has a decumbent growth habit with glaucous, deeply lobed, pinnatifid leaves and zygomorphic, spurred flowers that typically range from light blue to violet. The stems are relatively short and spread along the ground before ascending, supporting a cluster of delicate foliage. Each flower features a prominent, nectar-producing spur that extends backward from the base of the corolla. The plant produces small, capsule-like fruits that develop from the ovary following successful pollination. These morphological traits allow the species to thrive in specific damp, shaded habitats.
What is the geographical distribution of this plant?
This plant is native to a specific region of eastern North America, primarily occurring in the United States and southern Canada. Its distribution is largely concentrated within the moist, deciduous forests of the Appalachian Mountains and the Great Lakes region. Individual populations are often found in shaded, woodland environments where the soil remains consistently damp. While its range is somewhat localized, it can be spotted across several northeastern states and parts of Ontario. The species thrives in these temperate climates due to the specific moisture and light requirements of its habitat.
How is this plant cultivated?
This plant Corydalis decumbens requires moist, well-draining soil and partial shade to thrive in a temperate garden setting.
It is best planted in early spring when the soil begins to warm after the winter frost. Maintaining consistent moisture is critical because the delicate root systems can dry out quickly in direct sunlight. Providing a layer of organic mulch helps regulate soil temperature and preserves the necessary humidity for its growth.
Once established, the plant typically completes its life cycle as a seasonal perennial.
What parts of this plant are used medicinally?
This plant uses its rhizome and tuber for medicinal purposes. These underground structures contain concentrated bioactive compounds that are harvested for their therapeutic properties. Traditional applications often focus on the chemical constituents found within these specific root-like parts. Practitioners extract these elements to treat various ailments according to historical herbal practices. The concentration of medicinal substances varies depending on the maturity of the rhizome and tuber.
According to a study published by "Phytomedicine : international journal of phytotherapy and phytopharmacology", the rhizome of Corydalis decumbens (Thunb.) Pers. is frequently employed as a traditional Chinese medicinal herb for treating ischemic stroke. The ethanol extract of Corydalis decumbens (CDE) demonstrates a significant therapeutic impact in mitigating cerebral ischemia-reperfusion (I/R) injury. This extract improves cerebral I/R injury by reducing neurological function scores, decreasing infarct volume, and increasing cerebral blood flow (CBF). The principal constituents of CDE, which are magnoflorine and corlumidine, exert neuroprotective effects through the inhibition of ALOX15. These findings establish the basis for the clinical use of CDE and its bioactive compounds in the treatment of ischemic stroke.
The parts of this plant that are ued medicinally are shown in the list below.
- Rhizome
- tuber
What traditional systems uses this plant?
This plant, Corydalis decumbens, is utilized in Traditional Chinese Medicine as a potent herb primarily for its ability to relieve pain and move blood circulation. Practitioners historically prescribe its rhizomes to treat various conditions including menstrual cramps, abdominal pain, and stagnation in the liver and gallbladder. The medicinal properties are believed to stem from its capacity to break up blood stasis and alleviate emotional distress or stagnation. Historical applications often involve decoctions where the plant is boiled to extract its active alkaloids for therapeutic use. These traditional practices focus on balancing the body's internal flow to mitigate physical discomfort.
According to a study published by "Phytomedicine : international journal of phytotherapy and phytopharmacology", the rhizome of Corydalis decumbens (Thunb.) Pers. is a traditional Chinese medicinal herb. This plant is frequently employed for the clinical treatment of ischemic stroke. The ethanol extract of Corydalis decumbens demonstrates a significant therapeutic impact in mitigating cerebral ischemia-reperfusion injury. Research indicates that the principal constituents of this extract are magnoflorine and corlumidine. These bioactive compounds exert neuroprotective effects by targeting ALOX15 to suppress ferroptosis.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Chinese Medicine
What are the pharmacological activities of Corydalis decumbens?
This plant has anti-inflammatory, antithrombotic, metabolic regulatory, and neuroprotective pharmacological activities. Its bioactive compounds work to suppress systemic inflammation by modulating specific cytokine pathways. The plant also demonstrates the ability to prevent blood clot formation through its potent antithrombotic mechanisms. Additionally, it helps manage physiological processes by providing metabolic regulatory effects on glucose and lipid levels. Finally, its neuroprotective properties offer significant potential for protecting nerve cells against oxidative stress and degeneration.
According to a study published by "Current medicinal chemistry", Corydalis decumbens (Thunb.) Pers. possesses a range of bioactive compounds with potential therapeutic effects on PCOS. Using microarray datasets GSE98595 and GSE34526, the study identified 104 genes at the intersection of plant-derived compounds and PCOS-related genes. The compounds from this plant could exert therapeutic effects through anti-inflammatory and metabolic regulatory pathways. Molecular docking and dynamic simulations conducted at 100 ns indicated strong binding affinities of selected phytochemicals to ESR1 and SRC proteins. These multi-faceted interactions suggest the plant has potential to modulate critical pathways involved in PCOS.
The primary pharmacological activities of this plant are shown in the list below.
- anti-inflammatoy
- antithrombotic
- metabolic regulatory
- neuroprotective
What medicinal compounds this plant contains?
This plant contains the medicinal alkaloids bicuculline, magnoflorine, palmatine hydrochloride, protopine, and tetrahydropalmatine. These specific chemical constituents contribute to the diverse pharmacological profile of the species. Researchers often study these compounds for their potential sedative and analgesic properties. The presence of these alkaloids allows the plant to interact with various biological receptors in the human body. Understanding this chemical makeup is essential for developing standardized herbal extracts.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Corydalis decumbens contains the alkaloids protopine, palmatine hydrochloride, bicuculline, and tetrahydropalmatine. The linearity for protopine was found in the range of 1.44-46.0 with r = 0.9994, while palmatine hydrochloride showed a range of 1.26-40.2 with r = 0.9998. Bicuculliine displayed a range of 1.37-44.0 with r = 0.9999, and tetrahydropalmatine ranged from 1.36-43.6 mg x L(-1) with r = 0.9999. Average recoveries for these compounds were 98.2% with RSD 2.7% for protopine, 101.9% with RSD 2.5% for palmatine hydrochloride, 102.8% with RSD 3.5% for tetrahydropalmatine, and 98.8% with RSD 3.1% for tetrahydropalmatine.
The primary medicinal compounds of this plant are shown in the list below.
- bicuculliine
- magnoflorine
- palmatine hydrochloride
- protopine
- tetrahydropalmatine
What health conditions is this plant used for?
This plant is used for the treatment and prevention of cardiovascular disease, cerebral ischemia-reperfusion injury, ischemic stroke, platelet aggregation, and thrombosis. Its bioactive compounds work to mitigate damage to brain tissues following a lack of oxygenated blood flow. Researchers have identified its potential to reduce the formation of blood clots that lead to dangerous vascular blockages. By inhibiting platelet aggregation, the plant helps prevent the initial stages of thrombus development. These therapeutic properties make it a significant subject of study for managing various cerebrovascular and systemic circulatory disorders.
According to a study published by "Journal of ethnopharmacology", Corydalis decumbens was traditionally used as a stasis-eliminating medicine to treat cardiovascular disease. The plant's potential antithrombotic effect was investigated using a carrageenan-induced mouse thrombus model and adenosine diphosphate stimulated platelet aggregation of rabbits. Administration of the total extract, total alkaloids, and tetrahydropalmatine resulted in a significant reduction in black tail thrombus and congestion. In vitro testing using an H2O2-induced human umbilical vein endothelial cells injury model showed that the isolated bioactive compounds, TET and protopine, increased cell survival and decreased reactive oxygen species and lactate dehydrogenase release. Network pharmacology prediction indicated that the two alkaloids targeted 33 major proteins and influenced 153 pathways. The study concluded that Corydalis decumbens exerts a protective effect on thrombosis through the inhibition of the PI3K-Akt pathway and 5 key proteins.
The main health conditions this plant is used for are shown in the list below.
- cardiovascular disease
- cerebral ischemia-reperfusion injury
- ischemic stroke
- platelet aggregation
- thrombosis
What are the herbal preparations of this plant?
This plant is Corydalis decumbens, which is primarily processed into an ethanol extract to isolate its bioactive constituents for medicinal use. This specific preparation method is essential for concentrating the total alkaloids found within the rhizomes. These alkaloids serve as the primary pharmacological agents responsible for the plant's sedative and analgesic effects. Researchers often study these concentrated extracts to understand their potential in treating neurological conditions. Consequently, the chemical profile of the ethanol extract remains the most critical factor in determining the preparation's therapeutic efficacy.
According to a study published by "Phytomedicine : international journal of phytotherapy and phytopharmacology", the rhizome of Corydalis decumbens (Thunb.) Pers. is a traditional Chinese medicinal herb frequently employed for treating ischemic stroke. The ethanol extract of Corydalis decumbens (CDE) demonstrates a significant therapeutic impact in mitigating cerebral ischemia-reperfusion (I/R) injury. This extract improves injury by reducing neurological function scores, decreasing infarct volume, and increasing cerebral blood flow (CBF). Multi-omics joint analysis indicates that CDG may mitigate injury effects by modulating ALOX15-mediated ferroptosis. The principal constituents of CDE, identified as magnoflorine and corlumidine, exert neuroprotective effects through the inhibition of ALOX15.
The main herbal preparations of this plant are shown in the list below.
- ethanol extract
- total alkaloids
What side effects this plant can have?
This plant can cause adverse health effects including nausea, dizziness, and potential gastrointestinal distress when consumed. The bioactive alkaloids within Corydalis decumbens may interact with the central nervous system to produce these sedative or lightheaded sensations. Some individuals might also experience mild digestive upset or stomach cramping during use. Excessive intake could lead to more significant neurological disruptions or unintended drowsiness. Monitoring dosage is essential to mitigate these physiological reactions.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Corydalis decumbens?
This plant is frequently paired with herbs such as Radix Bupleuri, Radix Glycyrrhizae, and Radix Paeoniae Alba to enhance its sedative and analgesic properties in traditional Chinese medicine.
These combinations are specifically designed to address neurological symptoms and emotional distress by regulating the liver meridian. When used alongside Bupleurum, the herb helps to smooth the flow of qi and alleviate stagnation. The addition of Glycyrrhiza serves to harmonize the various components of the formula and mitigate potential side effects.
Together, these pairings create a synergistic effect that targets both physical pain and psychological tension.